Risks and benefits of celecoxib to prevent recurrent adenomas

N Engl J Med. 2006 Aug 31;355(9):950-2. doi: 10.1056/NEJMe068158.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenoma / prevention & control*
  • Adenomatous Polyps / prevention & control
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cardiovascular Diseases / chemically induced
  • Celecoxib
  • Colorectal Neoplasms / prevention & control*
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Humans
  • Neoplasms, Second Primary / prevention & control
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Secondary Prevention
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib